China Hospital Industry Development and Investment Report, 2012-2015
  • Mar.2013
  • Hard Copy
  • USD $2,400
  • Pages:120
  • Single User License
    (PDF Unprintable)       
  • USD $2,300
  • Code: XJT029
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,600
  • Hard Copy + Single User License
  • USD $2,600
China hospital industry has maintained stable growth in recent years, thanks to the market demand stimulus and stable influx of national investment. As of late 2011, China had a total of 21,979 hospitals, with the AAGR of 2.7% during 2005-2011. In particular, the proportion of non-public hospitals grew to 39.4%. In 2011, the revenue of China hospital industry totaled RMB1.2451 trillion, with the CAGR as high as 19.7%, while the gross margin was no more than 3.8%.

In recent years, Chinese government has unveiled a series of favorable policies to boost the reform of public hospitals, encourage and guide social capitals to rush into hospital industry. This move resulted in further maturity of investment operation mode of China hospital industry. Since 2010, privately-owned hospitals including Hong Kong Phoenix International Investment Group, YMCI, SL PHARM, Xi'an Kaiyuan Investment Group Company Limited and Jinling Pharmaceutical Company Limited have been restructured through trusteeship and M&A by public hospitals, while foreign enterprises have run their business in China via joint business, joint stock and joint venture, with orientation to Chinese top-grade medical market. Cases in point include United Family Hospital and ParkwayHealth.

Cases of Social Capital Flowing to Public Hospitals, 2010-2012

At present, the specialized hospitals in China are much favored in the marketization trend and little exposed to policy risk, thus, they are one of highlights when it comes to social capital investment. In 2011, the number of specialized hospitals in China surged from 2,682 in 2005 to 4,283, among which privately-owned ones accounting for 59.4%. And the revenue generated by the specialized hospitals amounted to RMB139.1bilion, with the CAGR in 2005-2011 reached 22.2% while the average gross margin realized 12.1%. In particular, the gross margin generated by ophthalmic hospitals and Cosmetic hospitals claimed 14.7% and 12.8%, respectively. In 2011, the gross margin of Aier Eye Hospital Group, TC Medical, and Mayinglong Pharm, the leading privately-run specialized hospitals in China, reported 55.3%, 47.2% and 39.4%, respectively.

The report highlights the followings:

20120114.gif China hospital industry market overview: number of hospitals of all sorts, operation, status quo of medical service, competition pattern, etc.
20120114.gif current development of specialized hospitals in China: overall operation, operation of ophthalmic hospitals, stomatological hospitals, plastic surgery hospitals, beauty hospitals, maternity hospitals, Children’s hospitals, and tumour hospitals as well as their development outlook;
20120114.gif development prediction of China hospital industry: status quo of China medical security, boosting urbanization’s influence on China healthcare market, supply and demand of medical resources in 2015;
20120114.gif investment in China hospital industry: related polices on social capital flowing into the hospital industry, operational efficiency comparison between privately-owned hospitals and public ones;
20120114.gif present operation, investment, mergers and development prediction of four major privately-owned specialized hospitals in China, six listed companies that have accessed into the hospital industry, and two foreign hospitals.

1. Overview of China Hospital Industry
1.1 Definition 
1.2 Classification 
1.3 Industry Chain

2. Overview of China Hospital Market 
2.1 Hospital Quantities 
2.1.1 Number of Hospitals Grows Steadily
2.1.2 Privately-Owned Hospitals Show Faster Growth Rate
2.1.3 Distinct Difference in Regional Distribution of Hospitals 
2.2 Revenue 
2.2.1 Total Revenue Surges Rapidly 
2.2.2 Revenue of General Hospitals Occupies A Lion’s Share
2.2.3 Proportion of Revenue from Medicine of General Hospitals On A Slow Decline 
2.3 Profit Level 
2.3.1 Average Gross Margin Maintains a Low Level
2.3.2 Gross Margin of General Hospitals Records the Lowest 
2.4 Medical Service 
2.4.1 Short Supply of Medical Resources 
2.4.2 Medical Personal Inadequacy Impacts the Development of Hospital Industry 
2.5 Competition Pattern 

3. Current Development of Specialized Hospitals in China 
3.1 Operation 
3.1.1 Proportion of Non-Public Specialized Hospitals Witnesses Steep Increase 
3.1.2 Revenue Generated by Specialized Hospitals Sees Rapid Growth 
3.1.3 Gross Margin of Specialized Hospitals Presents Sharp Rise against Last Year
3.2 Status Quo of Specialized Hospitals of All Kinds
3.2.1 Ophthalmic Hospital 
3.2.2 Stomatological Hospital 
3.2.3 Plastic Surgery & Cosmetic Hospital 
3.2.4 Maternity Hospital 
3.2.5 Children’s Hospital 
3.2.6 Tumour Hospital 

4. Development Forecast of China Hospital Industry 
4.1 Status Quo of China Medical Insurance 
4.1.1 Medical Insurance System 
4.1.2 Medical Insurance Nearly Realizes 100% Coverage
4.1.3 Medical Insurance for Serious Illness of Urban and Rural Residents 
4.2 Urbanization Bolsters Development of the Hospital Industry
4.2.1 Status Quo of Urbanization in China 
4.2.2 Urbanization Expects to Optimize Medical Insurance System 
4.2.3 Trans-regional Medical Insurance Settlement Is Expected to Realize Initiatively 
4.2.4 Urbanization Incrementation Depends on the Contribution of Medical Insurance System 
4.2.5 Medical Insurance Fund Balance Rate Will See Further Decrease 
4.2.6 Medical Resource Supply of County-Level Hospitals Will Improve 
4.2.7 Urbanization Will Encourage Central Government to Invest in Urban Medical Resources

5. Investment in China Hospital Industry 
5.1 Policy Environment Becomes Warm 
5.2 Competitiveness of Privately-Owned Hospitals 
5.2.1 Limited Size Effect of Public Hospitals 
5.2.2 Privately-Owned Hospitals See Higher Efficiency of Operation 
5.3 Investment Opportunities of Social Capital 
5.3.1 Specialized Medical Field
5.3.2 General Public Hospitals 
5.4 Development Direction and Operation Mode of Foreign Hospitals
5.4.1 Status Quo of Foreign Hospitals in China 
5.4.2 Development Direction of Foreign Hospitals
5.4.3 Operation Mode of Foreign Hospitals

6. Major Privately-Owned Hospitals in China 
6.1 Aier Eye Hospital Group
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 Medical Business
6.1.6 Prediction and Outlook
6.2 TC Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure 
6.2.4 Gross Margin 
6.2.5 Medical Business
6.2.6 Prediction and Outlook 
6.3 Mayinglong Pharm
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 Medical Business
6.3.6 Prediction and Outlook
6.4 Shanghai Fosun Pharmaceutical (Group)
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment 
6.4.6 Medical Business
6.4.7 Prediction and Outlook
6.5 Jinling Pharmaceutical Company Limited
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 Medical Business
6.5.6 Prediction and Outlook
6.6 Shinva Medical
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 Medical Business
6.6.6 Prediction and Outlook
6.7 Xi'an Kaiyuan Investment Group Company Limited
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Gross Margin
6.7.5 Medical Business
6.7.6 Prediction and Outlook
6.8 Inner Mongolia Free Han & Mongolia Pharmaceutical Co.,Ltd.
6.8.1 Profile
6.8.2 Operation
6.8.3 Revenue Structure
6.8.4 Gross Margin
6.8.5 Medical Business
6.8.6 Prediction and Outlook
6.9 Wuhan Jianmin Pharmaceutical Groups Corp. Ltd
6.9.1 Profile
6.9.2 Operation
6.9.3 Revenue Structure
6.9.4 Gross Margin
6.9.5 Medical Business
6.9.6 Prediction and Outlook
6.10 CMS Holdings Ltd.
6.10.1 Profile
6.10.2 Operation
6.10.3 Gross Margin
6.10.4 Medical Business
6.11 United Family Hospital
6.11.1 Profile 
6.11.2 Operation 
6.11.3 Medical Business 
6.12 ParkwayHealth
6.12.1 Profile
6.12.2 Operation
6.12.3 Medical Business
Types and Brief Introduction of Hospitals in China 
China Hospital Industry Chain 
Number of Hospitals in China, 2005-2011
Number of Hospitals in China by Level, 2006-2011
Number of Hospitals in China by Economic Type, 2006-2011
Number of Hospitals in China by Management Mode, 2006-2011 
Number of Hospitals in China by Institution Nature, 2006-2011
Number of Hospitals in China by Region, 2011 
Total Revenue of China Hospital Industry, 2005-2011 
Revenue Structure in China Hospital Industry by Source of Revenue, 2011 
Structure of Total Revenue of China Hospital Industry by Institution Nature, 2011 
Average Total Revenue of Each General Hospital in China, 2005-2011  
Average Revenue of Each General Hospital in China by Business, 2005-2011 
Average Net Income from Drugs of Each General Hospital in China and Makeup Percentage of Drugs, 2005-2011 
Average Gross Margin of China’s Hospitals, 2005-2011
Average Gross Margin of China’s Hospitals by Institution Nature, 2011 
Outpatient Visits of China’s Hospitals, 2005-2011
Number of Hospital Beds of China’s Hospitals, 2005-2011
Utilization of Beds in China’s Hospitals, 2005-2011
Number of Certified Doctors and Registered Nurses of China’s Hospitals, 2005-2011
Number of Medical Graduates of China’s Hospitals, 2005-2011
Proportion of Public and Non-Public Hospitals in Various Medical Fields of China, 2011 
Number of Specialized Hospitals in China, 2005-2011
Number of Specialized Hospitals in China by Economic Type, 2005-2011
Number of Specialized Hospitals in China by Classification, 2010-2011
Total Revenue of Specialized Hospitals in China, 2005-2011
Total Revenue of Specialized Hospitals in China by Classification, 2010-2011 
Gross Margin of Specialized Hospitals in China by Classification, 2011
Number of Ophthalmic Hospitals in China, 2006-2011
Revenue and Profit of Ophthalmic Hospitals in China, 2006-2011
Utilization of Hospital Beds and Service Efficiency of Doctors of China’s Ophthalmic Hospitals, 2006-2011
Number of Stomatological Hospitals in China, 2006-2011
Revenue and Profit of Stomatological Hospitals in China, 2006-2011
Utilization of Hospital Beds and Service Efficiency of Doctors of China’s Stomatological Hospitals, 2006-2011
Competition Comparison: TC Medical vs. Jiamei Stomatological vs. ARRAIL Dental 
Number of Plastic Surgery and Cosmetic Hospitals in China, 2006-2011 
Revenue and Profit of Plastic Surgery and Cosmetic Hospitals in China, 2006-2011
Number of Maternity Hospitals in China, 2006-2011
Revenue and Profit of Maternity Hospitals in China, 2006-2011
Utilization of Hospital Beds and Service Efficiency of Doctors of China’s Maternity Hospitals, 2006-2011
Number of Children’s Hospitals in China, 2006-2011
Revenue and Profit of Children’s Hospitals in China, 2006-2011
Utilization of Hospital Beds and Service Efficiency of Doctors of China’s Children’s Hospitals, 2006-2011
Number of Tumour Hospitals in China, 2006-2011
Revenue and Profit of Tumour Hospitals in China, 2006-2011
Utilization of Hospital Beds and Service Efficiency of Doctors of China’s Tumour Hospitals, 2006-2011
Composition of China Medical Insurance System 
Population Coverage of Medical Insurance System in China, 2005-2011 
Coverage of China Medical Insurance System, 2005-2011
Per Capita Expenditure of Three Kinds of Medical Insurances in China, 2009-2011 
Urbanization Rate of China, 2000-2011 
Healthcare Expenditure Structure of China, 2005-2011
Basic Insurances of China’s Urban Workers and Average Per Capita Fundraising of New Rural Cooperative Medical System, 2005-2011 
Medical Insurances of China’s Urban Workers and Balance Rate of New Rural Cooperative Medical System, 2005-2011
Favorable Polices on the Construction of County-Level Hospitals, 2009-2012 
Influence of In-Depth Urbanization to Medical Service, 2015  
Landmark Cases on Social Capitals Flowing to Medical Service Field in China, 1985-2012 
Policies Regarding Social Capitals Flowing to Medical Service Field in China, 2009-2012 
Policy Differences between Privately-owned Hospitals and Public Hospitals  
Entrustment Chain of Public Hospitals in China 
Average Per Capita Treatment Expenditure of Privately-owned Hospitals and Public Hospitals, 2012 
Brief Introduction to Medical Treatment in Northern Suzhou and Shenmu County, 2011 
Major Specialized Medical Services
Marketization Trend of China Medical Service System
Reform Mode of Established Property Rights System of Public Hospitals 
Pilot Cases of China’s Social Capitals Contributing to Public Hospital Restructuring, 1999-2012 
Partners and Major Medical Treatment Services of Sino-Foreign Joint Ventures in China Hospital Industry
Partners and Major Services of Sino-Foreign Joint Ventures in China Hospital Industry
Revenue and Net Income of Aier Eye Hospital Group, 2008-2012
Revenue of Aier Eye Hospital Group by Product, 2008-2012
Revenue of Aier Eye Hospital Group by Region, 2008-2012
Gross Margin of Aier Eye Hospital Group by Product, 2008-2012
Revenue and Net Income of Aier Eye Hospital Group, 2011-2015E
Revenue and Net Income of TC Medical, 2008-2012
Revenue of TC Medical by Product, 2008-2012
Revenue of TC Medical by Region, 2008-2012
Gross Margin of TC Medical by Product, 2008-2012
Client Orientation of TC Medical
Status Quo of Subsidiaries under TC Medical
Revenue and Net Income of TC Medical, 2011-2015E
Revenue and Net Income of Mayinglong Pharm, 2008-2012
Revenue of Mayinglong Pharm by Product, 2008-2012
Revenue of Mayinglong Pharm by Region, 2008-2012
Gross Margin of Mayinglong Pharm by Product, 2008-2012
Development History of Mayinglong Pharm Anorectum Chain Hospitals
Establishment Mode and Equity Structure of Anorectum Hospitals under Mayinglong Pharm
Net Income of Anorectum Hospitals under Mayinglong Pharm, 2011 
Comparison: Anorectum Hospitals under Mayinglong Pharm vs. Aier Eye Hospital Group vs. TC Medical
Revenue and Net Income of Mayinglong Pharm, 2011-2015
Revenue and Net Income of Shanghai Fosun Pharmaceutical (Group), 2008-2012
Revenue of Shanghai Fosun Pharmaceutical (Group)by Product, 2008-2012
Revenue of Shanghai Fosun Pharmaceutical (Group)by Region, 2008-2012
Gross Margin of Shanghai Fosun Pharmaceutical (Group) by Product, 2008-2011
R&D Costs and % of Total Revenue of Shanghai Fosun Pharmaceutical (Group), 2008-2012 
Established Regions and Expected Expansion of United Family Hospital, 2012 
Revenue and Net Income of Shanghai Fosun Pharmaceutical (Group), 2011-2014 
Revenue and Net Income of Jinling Pharmaceutical Company Limited, 2008-2012
Revenue of Jinling Pharmaceutical Company Limited by Product, 2008-2012
Revenue of Jinling Pharmaceutical Company Limited by Region, 2008-2012
Gross Margin of Jinling Pharmaceutical Company Limited by Product, 2008-2012
Revenue and Net Income of Jinling Pharmaceutical Company Limited, 2011-2015E
Revenue and Net Income of Shinva Medical, 2008-2012
Revenue of Shinva Medical by Product, 2008-2012
Revenue of Shinva Medical by Region, 2008-2012
Gross Margin of Shinva Medical by Product, 2008-2012
Revenue and Net Income of Shinva Medical, 2011-2014E
Revenue and Net Income of Xi'an Kaiyuan Investment Group Company Limited, 2008-2012
Revenue of Xi'an Kaiyuan Investment Group Company Limited by Sector, 2008-2012
Revenue of Xi'an Kaiyuan Investment Group Company Limited by Region, 2008-2012
Gross Margin of Xi'an Kaiyuan Investment Group Company Limited by Product, 2008-2012
Revenue and Net Income of Xi'an Kaiyuan Investment Group Company Limited, 2011-2015
Revenue and Net Income of Inner Mongolia Free Han & Mongolia Pharmaceutical Co.,Ltd., 2008-2012
Revenue of Inner Mongolia Free Han & Mongolia Pharmaceutical Co., Product, 2010-2012
Revenue of Inner Mongolia Free Han & Mongolia Pharmaceutical Co., Region, 2009-2012
Gross Margin of Inner Mongolia Free Han & Mongolia Pharmaceutical Co.,Ltd. by Product, 2008-2012
Investment and Operation Date of Inner Mongolia Free Han & Mongolia Pharmaceutical’s Chain Hospitals
Revenue and Net Income of Inner Mongolia Free Han & Mongolia Pharmaceutical Co.,Ltd., 2011-2015E
Revenue and Net Income of Wuhan Jianmin Pharmaceutical Groups Corp. Ltd, 2008-2012
Revenue of Wuhan Jianmin Pharmaceutical Groups Corp. Ltd by Product, 2008-2012
Revenue of Wuhan Jianmin Pharmaceutical Groups Corp. Ltd by Region, 2008-2012
Gross Margin of Wuhan Jianmin Pharmaceutical Groups Corp. Ltd by Product, 2008-2012
Revenue and Net Income of Wuhan Jianmin Pharmaceutical Groups Corp. Ltd, 2011-2015E
Revenue and Net Income of CMS, 2008-2012
Gross Margin of CMS by Product, 2008-2012
Service Network Coverage Regions of CMS, 2012 
Revenue of United Family Hospital, 2008-2012
Number of United Family Hospital’s Outlets by Region, 2013
Revenue of ParkwayHealth, 2006-2010
Revenue of ParkwayHealth in China, 2006-2010
Total Assets of ParkwayHealth in China, 2006-2009
Medical Treatment Centers and Services of ParkwayHealth in China

China Dental Industry Report, 2014-2018

Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...

China Medical Monitor Industry Report, 2014-2017

With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...

China Independent Clinical Laboratory Industry Report, 2014-2017

The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号